Gene: SLC35F2
Official Full Name: solute carrier family 35 member F2provided by HGNC
Gene Summary: Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20576 | SLC35F2 Knockout cell line (HeLa) | Human | SLC35F2 | 1:3~1:6 | Negative | Online Inquiry |
KO20577 | SLC35F2 Knockout cell line (HCT 116) | Human | SLC35F2 | 1:2~1:4 | Negative | Online Inquiry |
KO20578 | SLC35F2 Knockout cell line (HEK293) | Human | SLC35F2 | 1:3~1:6 | Negative | Online Inquiry |
KO20579 | SLC35F2 Knockout cell line (A549) | Human | SLC35F2 | 1:3~1:4 | Negative | Online Inquiry |
SLC35F2 Gene Knockout Cell Lines are specialized cellular models engineered to lack the SLC35F2 gene, which encodes a solute carrier protein implicated in various biological processes, including nucleotide sugar transport. By utilizing CRISPR-Cas9 gene editing technology, these knockout cell lines provide researchers with a powerful tool to investigate the functional role of SLC35F2 in cellular mechanisms, metabolic pathways, and disease states.
These cell lines serve as pivotal platforms for dissecting the biological pathways influenced by SLC35F2, particularly in the context of glycosylation and its implications in cancer progression, immune response, and cellular signaling. The absence of SLC35F2 allows for the assessment of downstream effects on glycan formation and modification, enabling researchers to identify potential therapeutic targets and biomarkers for clinical applications.
One of the standout features of our SLC35F2 Gene Knockout Cell Lines is their precision and reproducibility. Unlike traditional knockdown methods which can lead to incomplete silencing, our knockout models provide a complete gene disruption, allowing for more reliable experimental outcomes. This reliability is enhanced by stringent quality controls throughout the production process, resulting in cell lines that are consistent in performance and phenotypic stability.
Furthermore, these cell lines are versatile and can be adapted for various applications, including drug discovery, functional genomics, and personalized medicine approaches, making them indispensable tools for both academic and pharmaceutical research. Researchers and clinicians will find exceptional value in the possibility to uncover novel insights into the role of SLC35F2, ultimately contributing to advancements in targeted therapies and innovative treatment strategies.
Our company prides itself on expertise in biomanufacturing and genetic engineering, committed to supporting scientific endeavors with high-quality, reliable research tools that push the boundaries of discovery. By choosing our SLC35F2 Gene Knockout Cell Lines, researchers are equipped with state-of-the-art resources that facilitate groundbreaking research in the realm of cellular biology and beyond.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.